ATX 4.92% 6.4¢ amplia therapeutics limited

Ann: Promising Clinical Data 1b ACCENT Trial in Pancreatic Cancer, page-2

  1. 4,060 Posts.
    lightbulb Created with Sketch. 140
    Great preliminary results across all cohorts, especially considering each cohort were on ascending doses to the last.

    They only need an ORR of >5/26 to pass Ph2a, so these preliminary results are indicative of a strong chance of achieving that and more !

    Holding......hope for cancer patients!
 
watchlist Created with Sketch. Add ATX (ASX) to my watchlist
(20min delay)
Last
6.4¢
Change
0.003(4.92%)
Mkt cap ! $17.38M
Open High Low Value Volume
6.1¢ 6.6¢ 6.1¢ $28.65K 462.7K

Buyers (Bids)

No. Vol. Price($)
2 50642 5.8¢
 

Sellers (Offers)

Price($) Vol. No.
6.6¢ 131151 1
View Market Depth
Last trade - 16.10pm 21/06/2024 (20 minute delay) ?
ATX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.